Paper Details

  1. Home
  2. Paper Details

Budesonide - a new steroid for intranasal use. A double-blind clinical comparison between budesonide and placebo in patients with seasonal allergic rhinitis.

Author: LindqvistN, MøllerP, WarlandA

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Budesonide nasal spray was more effective than placebo in treating seasonal rhinitis in 29 patients. Side effects were mild and infrequent.
Paper Details　
Original Abstract of the Article :
Twenty-nine patients with seasonal rhinitis completed a double-blind study comparing budesonide nasal spray 200 micrograms b.i.d. with placebo. The patients were randomly assigned into two parallel groups. Symptoms were assessed over a treatment period of 3 weeks. There were statistically significan...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1398-9995.1981.tb01849.x

データ提供：米国国立医学図書館（NLM）

Budesonide: A New Intranasal Steroid for Seasonal Allergic Rhinitis

Seasonal allergic rhinitis (SAR) is a common condition that can significantly impact quality of life. This study compares the efficacy of budesonide nasal spray to placebo in patients with SAR. The researchers aimed to assess the effectiveness of budesonide in managing symptoms of SAR.

Budesonide: A Promising Treatment for Seasonal Allergies

The double-blind study found that budesonide nasal spray was significantly more effective than placebo in reducing symptoms of SAR. This finding suggests that budesonide may be a valuable treatment option for individuals suffering from seasonal allergies.

A Breath of Fresh Air for Allergy Sufferers

This research offers hope for individuals battling seasonal allergies. Budesonide, with its demonstrated efficacy in reducing SAR symptoms, could provide much-needed relief. It's like discovering a cool spring in the desert of allergy discomfort, offering a refreshing solution for those seeking relief from seasonal allergies.

Dr.Camel's Conclusion

This study is a testament to the power of targeted therapies. Like a desert traveler finding a well of fresh water, researchers have found a promising treatment for seasonal allergies. Budesonide nasal spray offers relief from the discomfort of SAR, making it a valuable tool for allergy sufferers.

Date :
  1. Date Completed 1982-02-12
  2. Date Revised 2019-08-21
Further Info :

Pubmed ID

7032343

DOI: Digital Object Identifier

10.1111/j.1398-9995.1981.tb01849.x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.